Human vitreous penetration of imipenem.
The purpose of this study was to determine imipenem concentrations in vitreous humor of non-infected human eyes. Ten patients undergoing vitrectomy were infused with a single dose of either 0.5g (5 patients) or 1g (5 patients) of imipenem. Vitreous humor was withdrawn 2 or 4 hours after the end of the infusion. Results differed in relation to the dose. After 0.5g, vitreous levels were stable (approximately 0.20 mg/l), but after 1g they were significantly higher (approximately 2 mg/l). These levels were above the minimum inhibitory concentration of imipenem for 90% (MIC 90) of the main species responsible for endophthalmitis.
Adenis
J P
JP
Department of Ophthalmology, CHU Dupuytren, Limoges, France.
Mounier
M
M
Salomon
J L
JL
Denis
F
F
D000368:Aged; D006801:Humans; D015378:Imipenem / Q000008:administration & dosage / Q000493:pharmacokinetics*; D007262:Infusions, Intravenous; D014821:Vitrectomy; D014822:Vitreous Body / Q000378:metabolism*
D015378:Imipenem